Cancer registries can provide measurement data to assess adherence to cancer care guidelines via which type of reporting?

• A. Reporting cases in 3 to 6 months after diagnosis
• B. Real-time reporting
• C. None of the above
• D. Both real-time and 3 to 6 month reporting

Answer: (B)

Real-time reporting provides timely data that reflects current clinical practice. When information on diagnosis, treatment decisions, and when care is delivered is captured as it happens, the registry can measure whether care aligns with the latest guidelines in a timely way. This allows for accurate assessment of adherence and supports prompt quality improvement efforts.

In contrast, collecting data 3 to 6 months after diagnosis means the information is delayed and may no longer reflect current practices or guideline recommendations. Such delays reduce the ability to monitor adherence in a timely, actionable manner, and can miss ongoing changes in practice or updates to guidelines. While retrospective analyses can be informative, real-time data offer the most effective and immediate measure of whether guideline-based care is being followed.